Brgx.Pk
BRGX.PK operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.
Business. BRGX.PK operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BRGX.PK operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.
The company's capital structure is highly leveraged, with total liabilities of $4.95 billion and total equity of -$4.54 billion, resulting in a negative debt-to-equity ratio of -0.49. Liquidity is constrained, as evidenced by a current ratio of 0.06 and only $69.38 million in cash and equivalents. The negative net income of -$1.54 billion and a free cash flow of -$1.53 billion indicate significant cash outflows, which could pressure the company's ability to meet short-term obligations.
Profitability metrics are mixed. The company reports a gross profit of $1.5 billion, but this is offset by an operating loss of -$1.24 billion and a net loss of -$1.54 billion. Return on equity is positive at 34.02%, but this is misleading due to the negative equity base. Return on assets is negative at -3.76%, indicating poor asset utilization and underperformance relative to industry norms.
The company's revenue concentration is not disclosed in the available data, but the negative equity and high leverage suggest a potential overreliance on a narrow set of revenue streams or geographic regions. The lack of segment or geographic breakdown in the financial data limits the ability to assess diversification risk.
The company's growth trajectory is uncertain. The available data does not provide forward-looking revenue guidance or historical growth rates, but the current financial performance suggests a challenging operating environment. The negative operating and net income, combined with a free cash flow deficit, indicate that the company is not generating sufficient cash to sustain operations or fund growth initiatives.
Risk factors include liquidity constraints, with a current ratio of 0.06 and negative net cash after subtracting total debt. The dilution risk is currently assessed as low, but the company's negative equity and high leverage could increase the likelihood of future equity issuances. The risk assessment also highlights the need for close monitoring of the company's capital structure and cash flow generation.
Recent events, including filings and transcripts, are not detailed in the available data. However, the company's financial performance and capital structure suggest that it may be under pressure to address liquidity and profitability concerns. The lack of disclosed capital expenditures and the negative free cash flow indicate that the company is not investing in growth or operational improvements.
- The company is highly leveraged with a negative equity position and a debt-to-equity ratio of -0.49.
- Despite a gross profit of $1.5 billion, the company reports a net loss of -$1.54 billion and a free cash flow deficit of -$1.53 billion.
- The company's liquidity is constrained, with a current ratio of 0.06 and only $69.38 million in cash and equivalents.
- The company's return on equity is positive at 34.02%, but this is misleading due to the negative equity base.
- The company's growth trajectory is uncertain, with no disclosed forward-looking guidance or historical growth rates.
- The company faces liquidity and profitability risks, with a need to address its capital structure and cash flow generation.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- BRGX.PK Market data — financials · 2026-05-27
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 112.0%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -19.2%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 4.1%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -9.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 100.0%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 100.0%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -48.5%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -95.2%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -1.09xDerived (calculated)
- Current ratio (FY 2025-12-31): 0.06xDerived (calculated)
- Return on assets (FY 2025-12-31): -375.6%Derived (calculated)
- Return on equity (FY 2025-12-31): 34.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 27.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 93.3%Derived (calculated)
- Gross margin (FY 2025-12-31): 81.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -34.3%Derived (calculated)
- Net margin (FY 2025-12-31): -83.2%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): -20.8%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 94.5%Derived (calculated)
- Total assets (annual): USD 410.99KSEC XBRL filing
- Operating cash flow (annual): USD 38.97KSEC XBRL filing
- Shareholders' equity (annual): USD -4.54MSEC XBRL filing
- Current liabilities (annual): USD 4.07MSEC XBRL filing
- Long-term debt (annual): USD 1.19MSEC XBRL filing